′-Deoxy-5′ ′ ′ ′-methylthioadenosine phosphorylase (MTAP) is an enzyme involved in purine and polyamine metabolism and is ubiquitously expressed in normal human tissues and cells. However, this enzyme has been found to be deficient in a variety of human cancers. Although the enzyme deficiency is known to be caused by MTAP gene deletion, human diffuse histiocytic lymphoma cell line DHL-9 without any detectable MTAP activity has been found to possess the intact MTAP gene. These lines of evidence suggested that promoter abnormality might cause the MTAP deficiency in DHL-9. Therefore, we analyzed the MTAP promoter region of DHL-9 and found the deletion of 14 bases in its sequence. We designated the allele lacking (GT) 6 Key words: MTAP -DHL-9 -Promoter activity -∆14 allele MTAP is an enzyme abundantly expressed in all normal human cells and tissues including erythrocytes and hematopoietic stem cells.
MTAP is an enzyme abundantly expressed in all normal human cells and tissues including erythrocytes and hematopoietic stem cells. 1, 2) The gene for the enzyme maps to the short arm of human chromosome 9 at band p21, where the cyclin-dependent kinase inhibitor genes for p16 and p15 also reside. [3] [4] [5] [6] MTAP catalyzes the irreversible phosphorolysis of MTA (a natural substrate of MTAP) to adenine and 5′-methylthio-D-ribose-1-phosphate, which are then recycled to adenine nucleotide and methionine, respectively, as an important salvage pathway of adenine and methionine in human cells. 7) Previous studies have shown that MTAP is deficient in various human malignant cell lines 2) and primary tumors such as pancreatic carcinoma, 8) brain tumors, 9) leukemias, [10] [11] [12] melanoma 13) and non-small cell lung cancers. 14, 15) MTAP enzyme deficiency was found to be caused by the gene deletion in all cancer cell lines but DHL-9, which lacks the enzyme activity without gene deletion. Neither MTAP mRNA nor the product protein was detected by RT-PCR or immunoblotting, respectively. In this study, genomic DNAs extracted from 210 Japanese volunteers were analyzed to determine the allelotype of MTAP promoter. We found a 14 bp deletion in the MTAP promoter of DHL-9 and determined its effect on the expression of the MTAP gene in vitro.
MATERIALS AND METHODS
Cloning of human wild-type and DHL-9 MTAP promoters A phage library constructed from human placenta DNA (Stratagene, La Jolla, CA) was screened with human MTAP cDNA probe as described previously. 3) A phage clone containing wild-type (WT allele) undeleted MTAP promoter was obtained and sequenced. Based upon the sequence data of MTAP promoter, two sets of PCR primers were synthesized to amplify the 1.2 kb promoter region. Promoter DNA purified from DHL-9 (∆14 allele) was analyzed by PCR using these sets of primers followed by DNA sequencing. PCR analysis of genomic DNA Another set of primers 3 To whom correspondence should be addressed. E-mail: nobori@clin.medic.mie-u.ac.jp Abbreviations: MTAP, 5′ ′ ′ ′-deoxy-5′ ′ ′ ′-methylthioadenosine phosphorylase; DHL-9, diffuse histiocytic lymphoma-9; MTA, 5′ ′ ′ ′-deoxy-5′ ′ ′ ′-methylthioadenosine; RT-PCR, reverse transcriptasepolymerase chain reaction; PBS, phosphate-buffered saline; SSM, slipped strand mispairing. was synthesized to diagnose ∆14 allele and WT allele as shown in Fig. 1 . PCR reactions were carried out in a total volume of 25 µl reaction mixture containing 100 ng genomic DNA as a template, 1× PCR buffer (10 mM TrisHCl, pH 8.0/50 mM KCl/1.5 mM MgCl 2 ), 250 µM of each of four deoxynucleoside triphosphates, 10 ng each of sense and antisense primers, and 1.25 units of Ex. Taq DNA polymerase (TaKaRa, Otsu, Shiga). The thermal cycling conditions consisted of an initial denaturation at 95°C for 7 min, followed by 40 cycles of denaturation at 94°C for 30 s, annealing at 56°C for 30 s and extension at 72°C for 30 s with a final extension at 72°C for 7 min. The amplification products were resolved by 3% MetaPhor agarose gel electrophoresis to differentiate the 95 bp product of the ∆14 allele from the 109 bp product of the WT allele. PCR products amplified from DNA samples containing ∆14 allele (DHL-9) and WT allele (human placenta) were subcloned into pCR 2.1 (Invitrogen, San Diego, CA). Purification of genomic DNA Lymphoblastoid cell lines established from members of a family (CEPH/UTAH PEDIGREE 1331) were obtained from Coriell Cell Repositories (Camden, NJ) for DNA extraction. Blood samples were collected from 210 Japanese volunteers, who had given their informed consent, and genomic DNA was purified by using the QIA amp system (Qiagen, Valencia, CA) according to the supplier's protocol. The volunteers were 40-60 years old and had visited hospital for a regular general health check-up.
Plasmid construction for transfection experiments
The plasmids containing either the ∆14 allele or the WT allele were digested with PstI restriction enzyme. PstI fragments were purified with the gel extraction kit (Qiagen) and were subcloned into pGEM-3z vector (Promega, Madison, WI) linearized with PstI. Then pGEM-3z vector containing the PstI fragment of MTAP promoter was digested with KpnI and HindIII restriction enzymes. Digested products were resolved by 1% agarose gel electrophoresis and KpnIHindIII fragments containing the MTAP promoter were purified. Purified MTAP promoter fragments (1.2 kb) were subcloned into the luciferase expression vector pGL2-Basic (Promega) linearized with KpnI and HindIII. Each construct was verified by DNA sequence analyses. Plasmid DNA was purified with a Midi preparation kit (Qiagen). Cell culture Human cervical carcinoma cell line HeLa S3 was grown in Dulbecco's modified Eagle's medium (Gibco-BRL, Grand Island, NY) supplemented with 10% fetal bovine serum, penicillin (50 units/ml) and streptomycin (50 mg/ml) in a humidified incubator at 37°C under an atmosphere of 5% CO 2 and 95% air. Transfection and luciferase reporter assay Transfection reactions were carried out in 12-well plates. HeLa cells were transferred into 12-well plates 24 h prior to the transfection procedure. HeLa cells were transfected at 60% to 70% confluence using Effectene transfection reagent (Qiagen) according to the manufacturer's protocol. To obtain the optimum transfection efficiency, conditions for transfection were pre-optimized as recommended by the supplier's protocol. In order to normalize the transfection efficiency of the constructs, cells were cotransfected with pCMVβ vector which was designed to express β-galactosidase from cytomegalovirus promoter (Clontech, Palo Alto, CA). Transient transfection was carried out for 24 h along with the positive (pGL2-Promoter) and negative (pGL2-Basic) controls in each set of experiment. 16, 17) The cells were then washed with 1× PBS twice and harvested. Cell lysates were prepared using 1× Reporter lysis buffer (Promega). Luciferase activity was measured by the luciferase assay system using a "PicaGene" luminescence kit (Toyo Ink, Tokyo) on the same day that cell lysates were obtained. The β-galactosidase activity was determined using the β-galactosidase enzyme assay system (Promega). The total protein of cell lysates was estimated with the BCA protein assay kit (Pierce, Rockford, IL). Results were normalized to the total protein content and β-galactosidase activity. Three different independent experiments were carried out and mean values were taken for the graphic presentation. Statistical significance was determined by Student's t test. There was no significant difference in luciferase activity between the WT allele and ∆14 allele of the MTAP promoter.
RESULTS AND DISCUSSION
Sequence analysis of MTAP promoter in DHL-9 The MTAP promoter was PCR-amplified from DHL-9 and human placenta, followed by direct DNA sequencing. By comparison with the sequence of the cloned MTAP promoter, DHL-9 was found to have a 14 bp deletion from −924 to −939 in its promoter region. A new set of primers was synthesized as shown in Fig. 1 to amplify the 109 bp Fig. 1 . MTAP promoter sequence harboring the WT allele and ∆14 allele. Underlined sequences were used as primers for PCR analysis.
product from the WT allele and the 95 bp product from ∆14 allele.
Analysis of Utah family 1331
Results on the Utah family showed that consecutive generations were also affected, indicating the genetic inheritance of the ∆14 allele in their offspring (Fig. 2) . The pattern of transmission of the ∆14 allele follows the principles of inheritance. Eight (57%) out of 14 family members had the ∆14 allele in heterozygous form, with males and females affected almost equally. The MTAP gene has already been mapped on human chromosome 9p21. Therefore, genetic inheritance of ∆14 allele in consecutive generation is autosomal dominant. Luciferase reporter assay Transfection results revealed that there was no significant difference of expression activity between the two constructs. Relative luciferase activity of the WT/WT allele and the ∆14/∆14 allele of MTAP gene turned out to be almost equal (Fig. 3) . This result suggested that the ∆14 allele is a normal DNA variation in which some bases within the MTAP promoter region are lacking without altering the expression of the gene as a whole in vitro. From this result, we can predict that the MTAP deficiency in DHL-9 is not due to the ∆14 allele.
The mechanism through which the ∆14 allele is generated is still unknown. Several years back, the SSM mechanism was first suggested by Efstratiadis et al. 18) and the same mechanism was proposed by Oron-Karni et al. 19) for the generation of short deletions. On the basis of the SSM mechanism, a single-stranded loop may be formed at the time of DNA replication, deleting 14 bases, followed by further elongation of the DNA strand. Distribution of the ∆ ∆ ∆ ∆14 allele in the Japanese population In the process of screening the samples from Japanese volunteers, PCR products showed three distinct categories of amplified DNA bands in ethidium bromidestained MetaPhor agarose gels (Fig. 4) . One of them was a Fig. 2 . Utah family analysis. Family pedigree showing the pattern of MTAP promoter sequences of the ∆14 allele and the WT allele in each member of the family. Each family member is given a separate number according to Coriell Cell Repositories. Male, square; female, circle; white, WT/WT; black and white, ∆14/WT; crossed, sample not available. (Table I) . This study suggested that there might be a 50% chance of having the ∆14 allele among the Japanese population. This ratio was quite different from Utah family's result. For genotyping analyses of the ∆14 allele, we had collected blood samples from many people who had come to the hospital for their regular general health check-up. They were from different families and ethnic groups, whereas the Utah family members were few in number and from a single family. These differences may account for the genotyping analysis differences between the Japanese population and the Utah family.
